Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Free Report) (TSE:I) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.10. Intellipharmaceutics International shares last traded at $0.10, with a volume of 2,065 shares traded.
Intellipharmaceutics International Stock Performance
The stock has a market cap of $3.31 million, a P/E ratio of -0.63 and a beta of 1.16. The firm’s 50 day moving average is $0.06 and its 200 day moving average is $0.06.
About Intellipharmaceutics International
Intellipharmaceutics International Inc, a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain.
Featured Stories
- Five stocks we like better than Intellipharmaceutics International
- 3 REITs to Buy and Hold for the Long Term
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Profitably Trade Stocks at 52-Week Highs
- Generac Powers Ahead on the Electrification Mega-Trend
- Utilities Stocks Explained – How and Why to Invest in Utilities
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.
